Pfizer and BioNTech to seek approval of booster dose for those aged 16 to 17
Health
- 30 November, 2021
- 05:20
Add Report.az to preferred Google sources
Stay up to date with the top news!
Pfizer and BioNTech are expected to seek authorization this week for a Covid-19 vaccine booster for teens 16 and 17 years old, Report informs, citing foreign media.
If approved, the additional Pfizer-BioNTech shot would mark the first vaccine booster for teens younger than 18.
The move comes as a new variant of coronavirus, known as omicron, spreads around the globe, worrying experts and pushing President Joe Biden to urge caution and again implore Americans to get inoculated.
Latest News
11:31
Assets of Azerbaijan's State Oil Fund reach $74 billion
Finance
11:26
AI systems, agents require strict control, management, official says
ICT
11:20
CBA delegation concludes participation in WB, IMF annual meetings
Finance
11:09
Rashad Hasanov: Azerbaijan strengthens human capital in IT sector
ICT
11:05
AI technologies require rethinking traditional security approaches, official says
ICT
11:03
Azeri Light crude rises to 118.53 per barrel
Energy
11:01
EU official: AI strengthens cybersecurity while creating new threats
ICT
10:59
Estonian expert: No country has yet emerged as an absolute leader in AI
ICT
10:55
Astok: Azerbaijan and Estonia need reliable systems for using AI
ICT